Trial intelligence / Profile preview

In-Hospital Extended-Release Naltrexone for Alcohol Use Disorder

NCT05087771Phase 4Withdrawn

Sponsor
University of Colorado Denver
Start
Mar 2022
Primary completion
Dec 2022
Modality
Small Molecules
01

Overview

A Phase 4 trial of naltrexone in alcohol use disorder (AUD), sponsored by University of Colorado Denver. Planned start Mar 2022; status: withdrawn.

02

Drugs

naltrexone
03

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT05087771.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05087771.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call